This study aimed to evaluate the variability of hemoglobin and the factors associated with the mortality of patients on hemodialysis and found that among all the variables evaluated, age, erythropoietin dose, and transferrin saturation were associated with a higher mortality in patients with stage 5 chronic kidney disease. This evidence concerns the gene EPO and chronic kidney disease.